期刊文献+

肺癌和癌前病变组织中FHIT、MSH2、p21蛋白表达及意义 被引量:2

Expression and significance of FHIT,MSH2 and p21 protein Expression in lung cancer and precancerous tissues
下载PDF
导出
摘要 目的探讨脆性组氨酸三联体(FHIT)、mutS同种组织蛋白2(MSH2)及p21蛋白表达在肺癌发生、发展中的意义。方法应用免疫组化SP法检测89份原发性肺癌组织(原发癌组)、12份淋巴结转移性肺癌组织(转移癌组)、12份肺癌癌前病变组织(癌前变组)及10份正常肺组织(对照组)中FHIT、MSH2及p21蛋白表达情况,分析各指标间相关性及其与肺癌临床病理参数的关系。结果与对照组比较,FHIT、MSH2及p21蛋白在其他三组中表达均下调(P(0.05);FHIT、MSH2蛋白表达与肺癌组织学类型、分化程度相关,p21蛋白表达与肺癌分化程度、临床分期及有无淋巴结转移有关(P均(0.05);FHIT和MSH2蛋白在原发癌组表达呈显著正相关(P<0.01),但均与p21蛋白表达无明显相关。结论 FHIT、MSH2及p21蛋白与肺癌发生、发展有关,联合检测三项指标可为临床预测疾病进展提供依据。 To investigate the roles of fragile histidine triad gene (FHIT) ,mutS homolog 2(MSH2) and p21 protein in the genesis and progress expression of lung cancer. Methods The expression of FHIT, MSH2 and p21 protein were detected by SP immunohistochemistry method , in tissues of 89 primary lung cancer( primary cancer group), 12 lymph node metastasis of lung cancer( metastatic carcinoma group), 12 precancerous lesion (precancerous lesion group) and 10 normal control(control group), the relationship between the indexes and clinicopathological parameters were analyzed. Results Compared with control group, the expression of FHIT, MSH2 and p21 protein decreased in the other three groups ( P 〈 0.05) ; The expression of FH1T and MSH2 protein was related to tumor histologicol types and degree of cell differentiation ,the expression of p21 protein was related to the differentiation degrees ,clinical stages and lymph node metastasis ( P 〈 0.05) ; There was significantly positive correlation between FHIT and MSH2 protein ( P 〈 0.01 ), but not obviously correlated with p21 protein. Conclusion The expression of FHIT ,MSH2 and p21 protein was related to the genesis and progress of lung cancer,joint detection of the three indexes may be useful to predict the development of lung cancer.
出处 《山东医药》 CAS 北大核心 2011年第3期15-17,共3页 Shandong Medical Journal
基金 天津市科委重点攻关课题资助项目(033804211)
关键词 肺肿瘤 肺癌 癌前病变 脆性组氨酸三联体 mutS同种组织蛋白2 P21蛋白 lung neoplasms,lung cancer precancerous lesion fragile histidine triad gene routs homolog 2 protein p21 protein
  • 相关文献

参考文献9

  • 1Andachi H,Yashima K,Keda M,et al.Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma[J].Br J Cancer,2002,87(4):44l-445.
  • 2刘婷,王新允,朱丛中,李艳,孙翠云,王爱香.KAI1在肺癌组织芯片中的表达及其生物学意义[J].中国肺癌杂志,2005,8(2):116-119. 被引量:2
  • 3Roz L,Gramegna M,Ishii H,et al.Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines[J].Proc Natl Acad Sci USA,2002,99(6):3615.
  • 4Tzao C,Tsai HY,Chen JT,et al.5' CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer[J].Eur J Cancer,2005,41(3):478.
  • 5Rohr UP,Rehfeld N,Geddert H,et al.Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer[J].Clin Cancer Res,2005,11(1):180-185.
  • 6de Fraipont F,Moro-Sibilot D,Michelland S,et al.Promoter methylation of genes in bronchial lavages:a marker for early diagnosis of primary and relapsing non-small cell lung cancer[J].Lung Cancer,2005,50(2):199-209.
  • 7Sengupta S,Chakrabarti S,Roy A.Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype[J].Cancer,2007,109(4):703-712.
  • 8Mori M,Mimori K,Masuda T,et al.Absence of Msh2 protein expression is associated with alteration in the FHIT locus and FHIT protein expression in colorectal carcinoma[J].Cancer Res,2001,61(20):7379-7382.
  • 9Sard L,Accomero P,Tornielli S,et al.The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control[J].Proc Natl Acad Sci USA,1999,96(15):8489-8492.

二级参考文献9

  • 1赖百塘.肺癌基础研究的几个热点[J].中华医学信息导报,2004,19(3):12-12. 被引量:3
  • 2Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med,1998,4(7):844-847.
  • 3Xie W, Mertens JC, Reiss DJ, et al. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res,2002,62(2):497-505.
  • 4董金堂 LambPW Rinker-SchaefferCW etal.KAI1 a metastasis suppressor gene for prostate cancer on human chromosome 11p11[J].2 Science,1995,268(5212):884-886.
  • 5Liu FS, Chen JT, Dong JT, et al. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. Am J Pathol,2001,159(5):1629-1634.
  • 6Uzawa K, Ono K, Suzuki H, et al. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinoge-nesis. Clin Cancer Res,2002,8(3):828-835.
  • 7Mhawech P, Dulguerov P, Tschanz E, et al. Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck. Br J Cancer,2004,90(2):471-475.
  • 8Hashida H, Takabayashi A, Tokuhara T, et al. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Int J Cancer,2002,97(4):518-525.
  • 9杨景,柳凤轩,阎晓初,贺光友,刘丽梅.肿瘤转移抑制基因KAI1在大肠癌进展中的作用[J].癌症,2003,22(5):533-536. 被引量:9

共引文献1

同被引文献25

  • 1苗英.胃黏膜癌前病变中p53、p21^(ras)蛋白表达与幽门螺杆菌感染的关系[J].胃肠病学和肝病学杂志,2004,13(6):616-618. 被引量:3
  • 2辛丹.p21蛋白在食道癌及食道良性增生性病变中的表达[J].齐齐哈尔医学院学报,2007,28(7):772-773. 被引量:2
  • 3Zhang R, Qin W, Xu GL, et al. A meta--analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorec- tal cancer[J]. Colorectal Dis, 2012, 14(3):e80-89.
  • 4Friedrichs K, Gluba S, Eidtmann H, et al. Over expression of p53 and prognosis in breast cancer[J]. Cancer, 1993, 72(12):3641--3647.
  • 5Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary non polyposis colon cancer[J]. Cell,1993, 75(5):1027-1038.
  • 6Gammie AE, Erdeniz N, Beaver J, et al. Functional characterization of pathogenic human MSH2 missense mutations in saccharomyces cerevisiae[J]. Genetics, 2007, 177(2):707-721.
  • 7Sidelnikov E, Bostick RM, Flanders WD, et ai. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms[J]. Cancer Epidemiol Biomarkers Prey, 2009, 18(11): 2965--2973.
  • 8Seifert M, Reichrath J. The role of the human DNA mismatch re- pair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer[J]. J Mol Histol, 2006, 37( 5--7):301-307.
  • 9Gu M, Bae YK, Kim AR, et al. Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas[J].Hepatogastroenterology, 2012, 59(119): 2228--2232.
  • 10Alkhalidi H, Kfoury H. Status of mismatch repair genes hMSH2 and hMSH6 in colorectal cancer in Saudi patients: an immunohisto- chemical analysis[J]. East Mediterr Health J, 2012, 18(11):1114-1117.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部